CLOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

JW Nutritional

JW Nutritional strives to maintain a high quality of business from communication all the way to product fulfillment to ensure the success of our clients.

Calhoun Senior Living

Calhoun Senior Living is a Anderson, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sandra Heath and Associates

Sandra Heath & Associates is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cambridge Healthtech Institute

Cambridge Healthtech Institute is a Needham Heights, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

St. Vincent Healthcare System

SVHC is a faith-based, not-for-profit health system that has served the people of Jacksonville and the surrounding communities since 1916